Develops a hormone-free, once-weekly oral contraceptive and a pipeline of multi‑indication therapeutics targeting conditions that disproportionately affect women. Builds foundation models of hormonal signaling to discover treatments for endometriosis, neurodegenerative disease and to improve women's healthspan and wellbeing.